The Technical Analyst
Bright Minds Biosciences [DRUG]
Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Bright Minds Biosciences Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $1.090
America/New_York / 25 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 4.71 mill |
| EPS: | -1.290 |
| P/E: | -0.840 |
| Earnings Date: | May 27, 2024 |
| SharesOutstanding: | 4.32 mill |
| Avg Daily Volume: | 0.0249 mill |
| RATING 2024-04-25 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Gr.Profit | n/a | n/a | ||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.840 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.14x |
| Company: PE -0.840 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$1.310 (20.19%) $0.220 |
| Date: 2024-04-25 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.956 - 1.224 ( +/- 12.29%) |
| ATR Model: 14 days |
Forecast:
16:00 - $1.090
Live Trading Signals (every 1 min)
Forecast
1: 15:47 - $1.095
Forecast 2: 16:00 - $1.090
Forecast 3: 16:00 - $1.090
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.090 (0.00% ) |
| Volume | 0.0131 mill |
| Avg. Vol. | 0.0249 mill |
| % of Avg. Vol | 52.35 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For DRUG
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
DRUG
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Latest Press Releases
2023-08-08 06:50:00 - Press Release
Bright Minds Biosciences Announces Positive Qeeg (quantitative Electroencephalogram) Data From Its First-in-human Phase 1 Study Of Lead Compound, Bmb-101
-- bmb-101 is a highly selective and potent 5-ht2c agonist being developed for the treatment of refractory epilepsies and other indications, such as psychosis, addiction, and impulse control disorders
2023-07-20 06:50:00 - Press Release
Bright Minds Biosciences Announces Positive Topline Data For Its First-in-human Phase 1 Study Of Lead Compound, Bmb-101
-- bmb-101 is a highly selective and potent 5-ht2c agonist being developed for the treatment of refractory epilepsies and other indications, such as psychosis, addiction, and impulse control disorders
2023-07-12 10:33:00 - Press Release
Cse Bulletin: Consolidation - Bright Minds Biosciences Inc. (drug)
Toronto, ontario--(newsfile corp. - le 12 juillet/july 2023) - bright minds biosciences inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every five (5) pre-consolidated common shares. as a result, the outstanding shares of the company will be reduced to approximately 3,772,071 common shares.
2023-07-11 06:50:00 - Press Release
Bright Minds Announces Effective Date Of Share Consolidation
Vancouver, british columbia, july 11, 2023 (globe newswire) -- bright minds biosciences inc. (cse: drug) (nasdaq: drug) (“bright minds” or the “company”), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, announces that, further to its news release on june 22, 2023, the company will consolidate its common shares (the “common shares”) on a five (5) to one (1) basis (the “consolidation”).
2023-04-10 06:50:00 - Press Release
Bright Minds Biosciences To Present At The 20th International Meeting Of The International Society For Serotonin Research
— presentation entitled "bmb-101: a selective 5-ht2c agonist in clinical trials with therapeutic utility" —
Latest News
2023-04-19 15:29:56 - PennyStocks
Penny Stocks To Buy? 10 Under $1 To Watch This Week
2023-04-10 06:50:00 - GlobeNewsWire
Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research
— Presentation entitled "BMB-101: A selective 5-HT2C agonist in clinical trials with therapeutic utility" —
2022-10-18 14:40:39 - InvestorPlace
What Is Going on With Bright Minds (DRUG) Stock Today?
Today's continued rally across equity markets is providing a bullish lift to many investors who have had their sentiment beat down to a great degree this year. While broad-based, certain sectors of the market are rallying more than others today.
2022-09-18 11:30:00 - PennyStocks
Making Money With Penny Stocks When the Market Crashes
How to make money with penny stocks during a market crash The post Making Money With Penny Stocks When the Market Crashes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-09-04 11:30:00 - PennyStocks
Which Strategies Are You Using With Penny Stocks in September?
Are you using these strategies for trading penny stocks right now? The post Which Strategies Are You Using With Penny Stocks in September?
2022-09-02 12:28:17 - PennyStocks
Best Penny Stocks To Buy Now? 4 To Watch This Month
Are these penny stocks to buy now or avoid in September? The post Best Penny Stocks To Buy Now?
2022-08-29 06:00:00 - PennyStocks
Hot Penny Stocks to Watch in the First Week of September
What to know about buying penny stocks today The post Hot Penny Stocks to Watch in the First Week of September appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-08-28 11:30:00 - PennyStocks
Top Strategies for Buying Penny Stocks in September? 3 to Know
Use these strategies for buying penny stocks in September The post Top Strategies for Buying Penny Stocks in September? 3 to Know appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-08-25 06:00:00 - PennyStocks
Can These Penny Stocks Explode Today? 3 to Watch
Here's what you need to know about buying penny stocks on August 25th The post Can These Penny Stocks Explode Today? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
2022-08-24 14:34:02 - InvestorPlace
Why Are Psychedelics Stocks Up Today?
Psychedelics stocks, like Seelos Therapeutics (NASDAQ: SEEL ), Scisparc (NASDAQ: SPRC ) and Bright Minds Biosciences (NASDAQ: DRUG ), are taking off today. This morning, it was announced that the Michael J.